HEADER PROTEIN BINDING 20-DEC-07 3BQD TITLE DOUBLING THE SIZE OF THE GLUCOCORTICOID RECEPTOR LIGAND BINDING POCKET TITLE 2 BY DEACYLCORTIVAZOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOCORTICOID RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: GLUCOCORTICOID RECEPTOR LIGAND BINDING DOMAIN (RESIDUES COMPND 5 525-777); COMPND 6 SYNONYM: GR, NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: NUCLEAR RECEPTOR COACTIVATOR 1 ISOFORM 1 COACTIVATOR MOTIF COMPND 13 (RESIDUES 739-751); COMPND 14 SYNONYM: NCOA-1, STEROID RECEPTOR COACTIVATOR 1, SRC-1, RIP160, COMPND 15 PROTEIN HIN-2, RENAL CARCINOMA ANTIGEN NY-REN-52; COMPND 16 EC: 2.3.1.48; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR3C1, GRL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: SYNTHETIC PEPTIDE DERIVED FROM GENE SEQUENCE KEYWDS GLUCOCORTICOID RECEPTOR, DEACYLCORTIVAZOL, SRC1, NUCLEAR RECEPTOR KEYWDS 2 COACTIVATOR 1 ISOFORM 1, DIMER INTERFACE, HORMONE BINDING POCKET, KEYWDS 3 CHARGE CLAMP, COACTIVATOR, ALTERNATIVE INITIATION, ALTERNATIVE KEYWDS 4 SPLICING, CHROMATIN REGULATOR, CYTOPLASM, DISEASE MUTATION, DNA- KEYWDS 5 BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, KEYWDS 6 POLYMORPHISM, PSEUDOHERMAPHRODITISM, STEROID-BINDING, TRANSCRIPTION, KEYWDS 7 TRANSCRIPTION REGULATION, UBL CONJUGATION, ZINC, ZINC-FINGER, KEYWDS 8 ACYLTRANSFERASE, CHROMOSOMAL REARRANGEMENT, PROTO-ONCOGENE, KEYWDS 9 TRANSFERASE, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR H.E.XU REVDAT 6 30-AUG-23 3BQD 1 REMARK REVDAT 5 20-OCT-21 3BQD 1 REMARK SEQADV HETSYN REVDAT 4 24-FEB-09 3BQD 1 VERSN REVDAT 3 27-MAY-08 3BQD 1 CRYST1 REVDAT 2 11-MAR-08 3BQD 1 JRNL REVDAT 1 15-JAN-08 3BQD 0 JRNL AUTH K.SUINO-POWELL,Y.XU,C.ZHANG,Y.G.TAO,W.D.TOLBERT,S.S.SIMONS, JRNL AUTH 2 H.E.XU JRNL TITL DOUBLING THE SIZE OF THE GLUCOCORTICOID RECEPTOR LIGAND JRNL TITL 2 BINDING POCKET BY DEACYLCORTIVAZOL. JRNL REF MOL.CELL.BIOL. V. 28 1915 2008 JRNL REFN ISSN 0270-7306 JRNL PMID 18160712 JRNL DOI 10.1128/MCB.01541-07 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.60 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 98101.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.2 REMARK 3 NUMBER OF REFLECTIONS : 20243 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1583 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 69.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2405 REMARK 3 BIN R VALUE (WORKING SET) : 0.4830 REMARK 3 BIN FREE R VALUE : 0.4750 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 186 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.035 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2149 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 63 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 73.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 18.17000 REMARK 3 B22 (A**2) : 18.17000 REMARK 3 B33 (A**2) : -36.34000 REMARK 3 B12 (A**2) : 20.47000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM SIGMAA (A) : 0.78 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.48 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.72 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.010 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 49.20 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : DAC.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : DAC.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3BQD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-DEC-07. REMARK 100 THE DEPOSITION ID IS D_1000045836. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUL-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 5ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI 1 1 1 REMARK 200 OPTICS : MONOCHROMATOR SI 1 1 1 REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20243 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 9.90000 REMARK 200 FOR THE DATA SET : 32.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1M2Z REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.3 M AMMONIUM SULFATE, 100 MM TRIS, REMARK 280 8% GLYCEROL, 3 MM N-HEXADECYL-BETA-MALTOSIDE, PH 8.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 62 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+2/3 REMARK 290 6555 X-Y,X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.66667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 43.33333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 86.66667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 43.33333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2060 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 523 REMARK 465 SER A 524 REMARK 465 ALA B 739 REMARK 465 GLN B 740 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN B 741 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO A 526 N LEU A 528 1.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 549 N - CA - C ANGL. DEV. = -23.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 526 -101.80 -47.65 REMARK 500 GLN A 527 -39.55 15.34 REMARK 500 TYR A 548 -144.02 114.07 REMARK 500 ASP A 549 53.45 110.86 REMARK 500 SER A 550 -7.67 -47.59 REMARK 500 SER A 551 13.57 -65.54 REMARK 500 VAL A 552 121.70 2.53 REMARK 500 ALA A 618 -169.16 161.53 REMARK 500 ASN A 619 -16.04 55.65 REMARK 500 PRO A 637 -64.69 -14.65 REMARK 500 ASP A 678 54.02 -91.37 REMARK 500 SER A 682 20.92 -152.65 REMARK 500 GLN A 683 -57.96 -28.79 REMARK 500 GLU A 705 -162.23 51.61 REMARK 500 ASN A 707 -154.34 -109.77 REMARK 500 SER A 708 -40.83 -150.43 REMARK 500 SER A 746 63.43 66.28 REMARK 500 ASN A 766 -9.55 -42.70 REMARK 500 LYS B 742 -55.06 -147.56 REMARK 500 SER B 743 68.64 39.46 REMARK 500 LEU B 744 -53.50 -10.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 640 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DAY A 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1M2Z RELATED DB: PDB REMARK 900 GLUCOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO REMARK 900 DEXAMETHASONE AND A TIF2 COACTIVATOR MOTIF DBREF 3BQD A 525 777 UNP P04150 GCR_HUMAN 525 777 DBREF 3BQD B 739 751 UNP Q15788 NCOA1_HUMAN 1429 1441 SEQADV 3BQD GLY A 523 UNP P04150 EXPRESSION TAG SEQADV 3BQD SER A 524 UNP P04150 EXPRESSION TAG SEQADV 3BQD SER A 602 UNP P04150 PHE 602 ENGINEERED MUTATION SEQRES 1 A 255 GLY SER LEU PRO GLN LEU THR PRO THR LEU VAL SER LEU SEQRES 2 A 255 LEU GLU VAL ILE GLU PRO GLU VAL LEU TYR ALA GLY TYR SEQRES 3 A 255 ASP SER SER VAL PRO ASP SER THR TRP ARG ILE MET THR SEQRES 4 A 255 THR LEU ASN MET LEU GLY GLY ARG GLN VAL ILE ALA ALA SEQRES 5 A 255 VAL LYS TRP ALA LYS ALA ILE PRO GLY PHE ARG ASN LEU SEQRES 6 A 255 HIS LEU ASP ASP GLN MET THR LEU LEU GLN TYR SER TRP SEQRES 7 A 255 MET SER LEU MET ALA PHE ALA LEU GLY TRP ARG SER TYR SEQRES 8 A 255 ARG GLN SER SER ALA ASN LEU LEU CYS PHE ALA PRO ASP SEQRES 9 A 255 LEU ILE ILE ASN GLU GLN ARG MET THR LEU PRO CYS MET SEQRES 10 A 255 TYR ASP GLN CYS LYS HIS MET LEU TYR VAL SER SER GLU SEQRES 11 A 255 LEU HIS ARG LEU GLN VAL SER TYR GLU GLU TYR LEU CYS SEQRES 12 A 255 MET LYS THR LEU LEU LEU LEU SER SER VAL PRO LYS ASP SEQRES 13 A 255 GLY LEU LYS SER GLN GLU LEU PHE ASP GLU ILE ARG MET SEQRES 14 A 255 THR TYR ILE LYS GLU LEU GLY LYS ALA ILE VAL LYS ARG SEQRES 15 A 255 GLU GLY ASN SER SER GLN ASN TRP GLN ARG PHE TYR GLN SEQRES 16 A 255 LEU THR LYS LEU LEU ASP SER MET HIS GLU VAL VAL GLU SEQRES 17 A 255 ASN LEU LEU ASN TYR CYS PHE GLN THR PHE LEU ASP LYS SEQRES 18 A 255 THR MET SER ILE GLU PHE PRO GLU MET LEU ALA GLU ILE SEQRES 19 A 255 ILE THR ASN GLN ILE PRO LYS TYR SER ASN GLY ASN ILE SEQRES 20 A 255 LYS LYS LEU LEU PHE HIS GLN LYS SEQRES 1 B 13 ALA GLN GLN LYS SER LEU LEU GLN GLN LEU LEU THR GLU HET DAY A 301 36 HETNAM DAY 1-[(1R,2R,3AS,3BS,10AR,10BS,11S,12AS)-1,11-DIHYDROXY-2, HETNAM 2 DAY 5,10A,12A-TETRAMETHYL-7-PHENYL-1,2,3,3A,3B,7,10,10A, HETNAM 3 DAY 10B,11,12,12A-DODECAHYDROCYCLOPENTA[5,6]NAPHTHO[1,2- HETNAM 4 DAY F]INDAZOL-1-YL]-2-HYDROXYETHANONE HETSYN DAY DEACYLCORTIVAZOL; 11BETA,17,21-TRIHYDROXY-6,16ALPHA- HETSYN 2 DAY DIMETHYL-2'-PHENYL-2'H-PREGNA-2,4,6-TRIENO(3,2-C) HETSYN 3 DAY PYRAZOL-20-ONE; 2'H-PREGNA-2,4,6-TRIENO(3,2-C)PYRAZOL- HETSYN 4 DAY 20-ONE; 11,17,21-TRIHYDROXY-6,16-DIMETHYL-2'-PHENYL- HETSYN 5 DAY (11BETA,16ALPHA)-(9CI); 6,16A-DIMETHYLPREGNA-4,6- HETSYN 6 DAY DIENE-11B,17A,21-TRIOL-20-ONE-2'-PHENYL-(3,2-C)- HETSYN 7 DAY PYRAZO FORMUL 3 DAY C30 H36 N2 O4 FORMUL 4 HOH *63(H2 O) HELIX 1 1 THR A 531 GLU A 540 1 10 HELIX 2 2 SER A 555 ALA A 580 1 26 HELIX 3 3 GLY A 583 LEU A 587 5 5 HELIX 4 4 HIS A 588 SER A 616 1 29 HELIX 5 5 ASN A 630 THR A 635 1 6 HELIX 6 6 MET A 639 LEU A 656 1 18 HELIX 7 7 SER A 659 LEU A 672 1 14 HELIX 8 8 SER A 682 ARG A 704 1 23 HELIX 9 9 SER A 708 ASP A 742 1 35 HELIX 10 10 PRO A 750 GLY A 767 1 18 HELIX 11 11 SER B 743 LEU B 749 1 7 SHEET 1 A 2 LEU A 621 ALA A 624 0 SHEET 2 A 2 LEU A 627 ILE A 629 -1 O ILE A 629 N LEU A 621 SHEET 1 B 2 SER A 674 PRO A 676 0 SHEET 2 B 2 ILE A 769 LYS A 771 -1 O LYS A 770 N VAL A 675 SITE 1 AC1 18 LEU A 563 ASN A 564 LEU A 566 GLY A 567 SITE 2 AC1 18 GLN A 570 MET A 601 MET A 604 ALA A 605 SITE 3 AC1 18 ALA A 607 LEU A 608 ARG A 611 PHE A 623 SITE 4 AC1 18 GLN A 642 LEU A 732 TYR A 735 CYS A 736 SITE 5 AC1 18 THR A 739 ILE A 747 CRYST1 93.800 93.800 130.000 90.00 90.00 120.00 P 62 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010661 0.006155 0.000000 0.00000 SCALE2 0.000000 0.012310 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007692 0.00000